- Blood Pressure Kit: Your Doctor At Home By : Roberto Modesto
A blood pressure kit helps you keep an eye on your health and potentially saves your precious life. Read on to know more about it. - An Equal Opportunity Killer: Heart disease in women. By : Judah98 Friedman98
Venous ulcers are the most common found leg ulcers. Venous insufficiency is the inappropriate functioning of the one-way valves in the veins. Generally veins take blood from the feet, ankles and the lower legs to the heart. Venous disease affects the quality of life of the person infected and also the costs can be quite cumbersome. Although the pathological causes leading to this venous ulceration are unknown, a better realization of the current pathophysiology of ulceration will lead to novel approaches in its control and management. In addition to the compression therapy, latest kinds of wound dressings, surgical modalities, bioengineered tissue, topical and systemic therapeutic agents can be used. - New Frontiers in Cardiac Imaging: Cardiac CT Provides diagnostic utility and By : Judah98 Friedman98
Atrial Fibrillation (AF) or afib as it is popularly known is an abnormal rhythm in the beating of the heart (Cardiac arrhythmia), which involves the two atria of the heart. Atrial Fibrillation can be generally identified while noting a pulse. AF is the commonest arrhythmia and the risk of contacting it increases with age. Though it is not life threatening in itself, it may lead to further complications like chest pain, fainting, congestive heart failure. AF is the leading cause of heart stroke now. Left unattended and without medication, Atrial fibrillation may lead to a chronic condition leading to a stroke and then to death. Stroke risk increases 5 times with AF, and the frequency of AF is over 10% for those above 80 years of age. Over 2 million people in the United States have AF. - Treatment and Diagnosis of Cardiovascular Disease By : Robert Baird23
Diagnosing cardiovascular disease is becoming more sophisticated. Diagnosis begins with a medical examination and patient history. - Spiritual Interventions Do Not Help Recovery, But May Relax Heart Patients By : Cardiology News
Stress and depression can increase the risk of heart disease and impair recovery from heart attacks. And although not as soundly proven, optimistic and relaxed patients seem to weather illness better than the gloomy and anxious. Can spiritual interventions make tests and treatments easier for patients? Like many areas of alternative medicine, this has not been fully investigated, reports the December 2006 issue of Harvard Men's Health Watch. But two studies serve as models for further research. - FDA Meets On Controversial Stents: Cardiologist Can Discuss By : Cardiology News
The FDA meets with experts today to discuss if the use of drug-coated stents, metal tubes used to prop open the arteries of heart patients to improve blood flow, increases the risk of death and raises other safety concerns. - Assessment Of A Race-Based Pharmaceutical Drug By : Cardiology News
BiDil is the first drug approved by the Food and Drug Administration marketed for a single racial-ethnic group, African-Americans, in the treatment of congestive heart failure. This analysis discusses background issues to help prepare physicians to counsel patients about this controversial drug. - Genetic Experts Investigate Causes Of Harmful Metabolic Disorder By : Cardiology News
University of Cincinnati (UC) researchers have received more than $1.6 million from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study genetic causes of metabolic syndrome, a disorder that can lead to cardiovascular disease and diabetes. - Researchers Find That Screening Children For Heart Disease Risk Helps To Identify Parents At Risk By : Cardiology News
Screening children for risk factors associated with cardiovascular disease can help identify parents at risk for the condition, providing an opportunity for medical intervention in both children and their parents, according to research at Children's Hospital of Pittsburgh of UPMC. - Data Presented To FDA Panel Show TAXUS Drug-Eluting Stents As Safe As Bare-Metal Stents And Far By : Cardiology News
Boston Scientific Corporation (NYSE: BSX) today presented data on its long- term randomized clinical trials to a special U.S. Food and Drug Administration (FDA) panel, showing that the TAXUS(R) paclitaxel-eluting coronary stent is as safe as bare-metal stents and far more effective in keeping arteries open and reducing the need for repeat procedures. - Cardium's Generx Advances To Phase 3 Following Meeting With FDA By : Cardiology News
Cardium Therapeutics, Inc (OTC Bulletin Board: CDTP) announced that Generx(TM) (alferminogene tadenovec) is to be advanced to a Phase 3 clinical trial in women as a potential treatment for myocardial ischemia (insufficient blood flow within the heart muscle), following an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA). - Real-World Taxus(R) Stent Data Confirm Favorable Outcomes For Patients With Complex Coronary Artery By : Cardiology News
Boston Scientific Corporation (NYSE: BSX) today presented data on its 7,000- patient ARRIVE I and II registries of real-world patients -- including those with complex lesions -- to a special U.S. Food and Drug Administration (FDA) panel. - FDA To Consider Safety Of Coated Stents By : Cardiology News
Are further studies or new warnings needed on the safety of coated stents? Practitioners and patients await the outcome of the FDA's meetings planned for this Thursday and Friday. - FDA Panel To Hear New Data From Kaiser Permanente Experts On Drug-eluting Heart Stents By : Cholesterol News
On Friday, December 8th, Kaiser Permanente physicians will present new research based on Kaiser Permanente data gleaned from cardiovascular patients in the Colorado and Northern California regions to the Food and Drug Administration's committee looking into safety concerns being raised for patients treated with drug-eluting stents. - Timely Treatment Of Heart Attacks: Results From The AMI-QUEBEC Study By : Cardiology News
Huynh and coauthors report the findings of the AMI-QUEBEC Study, which looked at delays in providing reperfusion therapy, potentially life-saving treatment to restore blood flow to the heart muscle, to patients with ST-segment elevation acute myocardial infarction (STEMI) who were admitted to 17 hospitals in Quebec in 2003. - FDA Advisory Committee To Examine Potential Safety Risks Of Drug-Coated Cardiac Stents By : Cardiology News
An FDA panel on Thursday and Friday will examine whether drug-eluting stents increase the risk of life-threatening blood clots and whether the potential risk outweighs the benefits of the stents for some patients, the Wall Street Journal reports. Drug-coated stents, which are sold in the U.S. by Boston Scientific and Johnson & Johnson, are designed to prevent scar tissue from forming in arteries after angioplasty. - Take Heart: Study Validates Folic Acid Decreases Risk Of Heart Disease And Stroke, Reinforces Animi- By : Cardiology News
A new study in British Medical Journal reviews the scientific evidence published in previous studies that supports the use of folic acid as a way of reducing the risk of heart disease and strokes. - American Heart Association Statement On Use Of Drug-Eluting Coronary Stents By : Cardiology News
A coronary stent is a wire mesh tube used to prop open a previously blocked artery to the heart - Double Survival Rates In Sudden Cardiac Arrest Victims In Lund, Sweden By : Cardiology News
In the Swedish National Registry of Cardiac Arrest, the city of Lund has for the last three years (2003-2005) claimed the top position in one-month survival rates of out-of-hospital cardiac arrest victims. - Regadenoson Meets Primary Endpoint In Second Phase 3 Clinical Trial By : Cardiology News
CV Therapeutics, Inc. (Nasdaq: CVTX) and Astellas Pharma US, Inc. announced today that the second of two Phase 3 clinical studies of regadenoson met its primary endpoint. A prior identically designed Phase 3 study, completed in 2005, also met its primary endpoint. - Wisconsin Heart Hospital First In U.S. To Use C-Port(R) XA Device During Bypass Surgery By : Cardiology News
A team of Wisconsin Heart Hospital surgeons led by nationally-renowned cardiothoracic surgeon Husam H. Balkhy, M.D. were the first in the United States to use the latest-generation, fully-automated device to attach a blood vessel graft during coronary artery bypass surgery. - How Safe Are Drug Coated Stents? By : Cardiology News
Drug-coated stents are very small coils which are placed in your artery and slowly release a medicine which makes sure the artery does not clamp shut again. Over six million people around the world have received this 'medical wonder' - people who suffered chest pain and/or heart attacks - Scientists Work To Identify Genes That Contribute To Early Atherosclerosis By : Cardiology News
Scientists at Wake Forest University Baptist Medical Center and colleagues at four other medical centers have launched a $10 million multi-year study to identify genes that may contribute to early atherosclerosis. - Natural Toxin Responsible For Cell Death Following Blood 'Reflow' Injury By : Cardiology News
Researchers at Johns Hopkins have discovered what they believe is the "smoking gun" responsible for most tissue and organ damage after a period of blood oxygen loss followed by a sudden restoration of blood oxygen flow. - Cytokinetics Announces Oral Bioavailability Results For CK-1827452 By : Cardiology News
Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that the results from an oral bioavailability study evaluating CK-1827452 - The Impact Of Immunosuppressive Medications On Cardiovascular Events In RA Patients By : Cardiology News
Patients with rheumatoid arthritis (RA) have an increased risk of heart attack and stroke. - Contact: Dr. Thomas Schlake
By : Cardiology News
The scientific evidence is strong enough to justify using folic acid as a cheap and simple way of reducing heart disease and strokes, say researchers in this week's BMJ. - Technology Predicts Outcome Of Child Heart Surgery By : Cardiology News
Georgia Tech and Emory University researchers have developed an innovative new technology that will help pediatric cardiac surgeons design and test a customized surgical procedure before they ever pick up a scalpel. - MRI Helps Identify Older Athletes At Risk For Heart Attack By : Cardiology News
A magnetic resonance imaging (MRI) study of healthy marathon runners over age 50 showed that cardiovascular disease occurs among seemingly healthy endurance athletes and may be difficult to distinguish from the effects of training the heart muscle. - Researchers Use Computed Tomography To Study Effects Of Fat Around The Heart By : Cardiology News
With a $1.5 million grant from the National Institutes of Health, researchers at Wake Forest University School of Medicine are exploring whether fat stored around the heart accelerates the development of atherosclerosis. - Heart Attack-Related Depression Puts Patients At Risk For Further Cardiovascular Emergencies By : Cardiology News
People who experience their first-ever bout of depression after having a heart attack are at greater risk for future heart problems than are patients who either don't become clinically depressed after the medical emergency or who were depressed even before the incident, new research shows. - Thailand PM To Open International Symposium In Bangkok On Stem Cell Therapy For The Failing Heart De By : Cardiology News
Bangkok Heart Hospital and TheraVitae are to co-sponsor a symposium December 1-3 at the Inter-Continental Hotel, Bangkok. Eminent researchers, heart specialists and biotechnology industry leaders from many countries will present the successes and challenges of treating patients with advanced heart diseases using stem cells. - Altered Sodium Channel Function Linked To Heart Failure By : Cardiology News
The results of a study, using mice and heart muscle cells from rabbits, by researchers from Georg-August-University Gottingen, Germany, have provided a potential molecular explanation for the abnormally rapid heartbeats known as ventricular tachyarrhythmias (VTs) that can cause the sudden death associated with heart failure. - NEJM Report On Cardiac Emergency Therapy Finds Single Medication Effective Vs. Combination Drugs By : Cardiology News
A study published in the New England Journal of Medicine led by Columbia University Medical Center and NewYork-Presbyterian Hospital researchers showed that an anti-clotting agent called bivalirudin (brand name Angiomax®), when used by itself to treat cardiac emergencies known as acute coronary syndromes (ACS), reduced the risk of major bleeding, a key risk for mortality, by 47 percent compared with the standard combination drugs. - LeMaitre Vascular, Inc. Completes Enrollment In EndoFit Clinical Study In China By : Cardiology News
LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today the enrollment of the 30th and final patient in the EndoFit Thoracic Stent Graft Clinical Study in China. - Spectrum Dynamics Receives 510(K) Clearance For The D-SPECT(TM) Cardiac System By : Cardiology News
SPECTRUM DYNAMICS today announced at the Radiological Society of North America (RSNA) annual meeting in Chicago that its D-SPECT(TM) Cardiac System has received 510(k) clearance from the U.S. - Master Cardiac Stem Cell Identified By Mass. General Researchers By : Cardiology News
Researchers from the Massachusetts General Hospital (MGH) Cardiovascular Research Center have discovered what appears to be a master cardiac stem cell, capable of differentiating into the three major types of cells that make up the mammalian heart. - Intensive Lipitor Therapy Reduced Heart Attacks And Strokes By 40 Percent In Patients With Heart By : Cardiology News
Results of a new analysis has shown that patients who have heart disease and chronic kidney disease who took atorvastatin 80mg reduced their relative risk of major cardiovascular events by 40% compared with patients taking the 10 mg dose of atorvastatin. - Report On Cardiac Emergency Therapy Finds Single Med Effective Vs. Combination Drugs By : Cardiology News
A study published today in the New England Journal of Medicine led by Columbia University Medical Center and NewYork-Presbyterian Hospital researchers showed that an anti-clotting agent called bivalirudin (brand name Angiomax®), when used by itself to treat cardiac emergencies known as acute coronary syndromes (ACS), reduced the risk of major bleeding, a key risk for mortality, by 47 percent compared with the standard combination drugs. - Studies Led By Rhode Island Hospital Confirm Safety And Efficacy By : Cardiology News
Following two studies of patients who were treated with cardiac stents, physicians at Rhode Island Hospital continue to recommend drug-eluting stents (DES) as a safe and effective treatment. - The New England Journal Of Medicine Publishes Angiomax(R) (Bivalirudin) ACUITY Trial Results By : Cardiology News
The New England Journal of Medicine today published results of ACUITY, a landmark clinical trial exploring the potential of the injectable anti-clotting medicine Angiomax(R) (bivalirudin) in patients experiencing cardiac emergencies known as acute coronary syndromes (ACS). - Insect Protein Effective For Treating Heart Enlargement, Arrythmias By : Cardiology News
Compounds known to play an important role in how insects develop from larvae to adults have been shown in a mouse model for congestive heart failure to be effective in preventing and reducing cardiac cell overgrowth and irregular heart rhythms, according to UC Davis research published in the early online edition of the Proceedings of the National Academy of Sciences. (http://www.pnas.org) - VCR -- FDA Approves Home Discharge For US Patients By : Cardiology News
Ventracor (ASX:VCR) has announced that the US Food & Drug Administration (FDA) has approved the company's request to allow home discharge of patients implanted with the VentrAssist under the US Feasibility Trial. - TB4 Is Essential For Blood Vessel Regeneration In Adult Hearts By : Cardiology News
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) (http://www.regenerx.com/) report that a study published in the advanced online edition of the journal Nature supported and elaborated TB4's significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans. - UCLA Neurologist Honored With American Heart Association's Stroke Council Award By : Cardiology News
Dr. Jeffrey L. Saver, professor of neurology at the David Geffen School of Medicine at UCLA and director of the UCLA Stroke Center, received the American Heart Association (AHA) Stroke Council Award Nov. 13 at the AHA Scientific Sessions Conference in Chicago. - Cause Of Exercise Intolerance In Heart Failure Patients Explored By Study By : Cardiology News
A new study shows that blood flow to the legs is relatively normal in people with diastolic heart failure, suggesting other potential causes of their inability to do everyday activities, according to researchers at Wake Forest University Baptist Medical Center. - Pine Tree Bark Reduces Side Effects In Hypertensive Patients By : Cardiology News
A study published in the October journal of Clinical and Applied Thrombosis/Hemostasis shows Pycnogenol® (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree reduced edema, a typical side-effect of antihypertensive medications, by 36 percent in patients taking these medications. - Orqis(R) Medical Reaches MOMENTUM Pivotal Trial Mid-Point With 100th Patient Enrollment By : Cardiology News
Orqis(R) Medical Corporation, a clinical-stage company developing devices for the treatment of congestive heart failure (CHF), announced today that the company achieved its mid-point milestone in the MOMENTUM Pivotal Trial by enrolling the 100th patient in the 200 patient study of the company's percutaneous Cancion(R) System. - Cardica Receives 510(k) Clearance For C-Port XA(TM) Distal Anastomosis System For Use In Coronary Ar By : Cardiology News
Cardica, Inc. (Nasdaq: CRDC) today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its C-Port xA(TM) Distal Anastomosis System in the U.S. - IAME, SCCT And ACCF Join Forces To Present Symposium On New Cardiovascular Technology In New York Ci By : Cardiology News
The Institute for Advanced Medical Education (IAME), in joint sponsorship with the Society for Cardiovascular Computed Tomography (SCCT) and co-sponsorship with the American College of Cardiology Foundation (ACCF), is presenting the first "Cardiovascular CT in New York" - Cardiovascular Events Reduced By Low-Dose Aspirin By : Cardiology News
Taking low-dose aspirin daily reduces the risk of heart attack and stroke, as well as the risk of dying, among patients who previously have had a heart attack or stroke but whose cardiovascular disease has stabilized, according to a new analysis by Duke University Medical Center cardiologists. - After Heart Attack Late Angioplasty No Better Than Drug Therapy By : Cardiology News
About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hour timeframe after a heart attack - FDA Approves Home Discharge For Patients By : Cardiology News
Ventracor (ASX: VCR) today announced that the US Food & Drug Administration (FDA) has approved the company's request to allow home discharge of patients implanted with the VentrAssist under the US Feasibility Trial. - Adult Heart Cells Learn To Heal By : Cardiology News
Cells in the outermost layer of the heart can be guided by a specific protein to move deeper inside and help to repair a failing adult heart. Research published today by Nature, reveals how thymosin B4, a protein already known for its ability to reduce muscle cell loB after heart attack, can instruct the heart to heal itself. - Anti-cancer Drug Shows Early Promise In Pulmonary Hypertension By : Cardiology News
A drug used to treat kidney cancer can prevent the development of pulmonary hypertension (high blood pressure in the lungs) in rodents, report researchers from the University of Chicago at the 2006 annual meeting of the American Heart Association, Nov. 12-15 in Chicago. There is no curative therapy for this condition. - British Stoicism Means More Die Of Heart Attack By : Cardiology News
Half of all Britons will stoically try to ignore possible heart attack signs, deciding to wait a while to see whether they will go away - Combination Of Personality Traits Increases Risk For Heart Disease By : Cardiology News
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center. - New Angioplasty Procedure Proving More Effective By : Cardiology News
Over the last several years angioplasty has exceeded coronary bypass surgery as the preferred way to treat coronary artery disease. The stents (narrow tubes inserted into the artery to facilitate blood flow) commonly used in the procedure are less invasive than open-heart surgery and offer greater convenience to the patient and the ability to perform more complex procedures. - Non-surgical Treatment Offers Alternative To Open Heart Surgery By : Cardiology News
A new method of treating mitral regurgitation (MR), the leaking of blood through the mitral valve into the heart chamber, provides a less-invasive alternative to open heart surgery. A study published in Journal of Interventional Cardiology found that a variety of advances have allowed for the potential treatment of MR through various catheter techniques, similar to angioplasty. - Chocoholics Teach Science A Sweet Lesson By : Cardiology News
Some "chocoholics" who just couldn't give up their favorite treat to comply with a study to test blood stickiness have inadvertently done their fellow chocolate lovers - and science - a big favor. - No Benefit To Mechanically Opening Arteries Days After A Heart Attack By : Cardiology News
In the days following a heart attack, patients who have no or mild symptoms and undergo a procedure called angioplasty to mechanically open their totally blocked coronary arteries do not reduce their risk of having another heart attack, going into heart failure, or dying, according to the results of a new study. - New Test May Identify Cardiovascular Disease Earlier By : Cardiology News
By analyzing the "trash" left in blood by the body's metabolism, a team of cardiologists and geneticists at Duke University Medical Center has found what may be new markers for measuring cardiovascular health, to complement such traditional measures as cholesterol and triglycerides. - Duke Researchers Highlight Gender Differences In Heart Failure By : Cardiology News
Women tend to live longer with heart failure than do men, and they also tend to have a less severe form of the disease, which is characterized by reduced performance of the heart muscle, according to a study by Duke University Medical Center cardiologists. - Columbia Scientists Presented Research Findings At AHA Scientific Sessions By : Cardiology News
Columbia University Medical Center scientists presented the latest research findings in a wide range of cardiovascular areas at the 2006 American Heart Association Scientific Sessions in Chicago, Nov.12-15. Columbia's groundbreaking medical research presentations at AHA this year included: - Cardiovascular Risks May Be Reduced By Diabetes Drug By : Cardiology News
A drug commonly used to increase the body's sensitivity to insulin may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to a study at the University of Illinois at Chicago College of Medicine. - Bioheart, Inc. Expands Clinical Trials Of Adult Myogenic Stem Cell Treatment For Heart Attack And Ad By : Cardiology News
Bioheart, Inc., a biotechnology company focused on the development of innovative cell therapies designed to repair areas of damaged muscle tissue in a patient's heart and improve cardiac function, is expanding its United States and European clinical trials of its MyoCell(TM) adult myogenic (muscle) stem cell composition and MyoCath(R) needle-injection catheter product candidates. - Bioheart, Inc. Expands Clinical Trials Of Adult Myogenic Stem Cell Treatment For Heart Attack And Ad By : Cardiology News
Bioheart, Inc., a biotechnology company focused on the development of innovative cell therapies designed to repair areas of damaged muscle tissue in a patient's heart and improve cardiac function, is expanding its United States and European clinical trials of its MyoCell(TM) adult myogenic (muscle) stem cell composition and MyoCath(R) needle-injection catheter product candidates. - Study Provides Further Support For Cardiovascular Safety Of Over-The-Counter Doses Of Naproxen Sodiu By : Cardiology News
Over the past two years, there has been documented concern about the cardiovascular safety of some pain relievers and arthritis treatments.(1) New data presented at the 70th annual meeting of the American College of Rheumatology (ACR) examine the platelet inhibition of over-the-counter (OTC) doses of naproxen sodium and the findings add further to the significant body of evidence surrounding the product's cardiovascular safety. - Preliminary Long-Term Clinical Data Show Promising Results For The CYPHER(R) Sirolimus-eluting By : Cardiology News
Preliminary three-year clinical data suggest the CYPHER(R) Sirolimus-eluting Coronary Stent may be a less invasive long-term alternative to coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease. These results were presented last night by Principal Investigator Patrick W. Serruys, M.D., Ph.D., The Thoraxcenter, Erasmus Medical Center, Rotterdam, Netherlands, during an award acceptance speech at the Council on Clinical Cardiology Dinner. - Micro Molecules Contribute Mightily To Heart Problem By : Cardiology News
Tiny bits of RNA - a chemical cousin of DNA - play a large role in causing enlargement of the heart, which is a major risk factor for heart failure and sudden death, researchers at UT Southwestern Medical Center have discovered. - Wide Racial Disparities Found In Coronary Artery Disease Deaths By : Cardiology News
African-American patients with coronary artery disease die at a significantly higher rate than white patients with the same degree of disease, according to an analysis of more than 20,000 patients by cardiologists at the Duke Clinical Research Institute. - Fast Test For Low Blood Flow In Dogs Detects Early Heart Trouble By : Cardiology News
Working with dogs and using the latest in imaging software and machinery, also known as a 64-slice CT scanner, Johns Hopkins heart specialists have developed a fast and accurate means of tracking blood that has been slowed down by narrowing of the coronary arteries. Researchers say it took them less than half the time of exercise stress tests and echocardiograms currently used to find early warning of vessels more likely to become blocked and cause heart attack. - MRI Detects Early Heart Damage In Patients With Sarcoidosis By : Cardiology News
To detect heart damage early in patients with the immune system disorder sarcoidosis, who are at elevated risk of dieing from heart problems, magnetic resonance imaging is twice as sensitive as conventional methods, according to a study by Duke University Medical Center cardiologists. - Cardiocerebral Resuscitation Better Than CPR For Out-Of-Hospital Cardiac Arrest By : Cardiology News
Survival rates following cardiac arrest went up 300 percent when emergency responders used Cardiocerebral Resuscitation, a new resuscitation approach for cardiac arrest pioneered at The University of Arizona Sarver Heart Center. Because the new technique does away with mouth-to-mouth breathing, it enhances the willingness to perform resuscitation in lay individuals. - New Data On Otsuka's Investigational Product For Hyponatremia Presented At American Heart By : Cardiology News
Results of the SALT-1 and SALT-2 trials, the two largest studies to date on hyponatremia(1), were presented earlier this week at the American Heart Association's Scientific Sessions 2006 (November 12-15) in Chicago. - Surface Logix Presents Positive Phase 1 Trial Data On SLx-4090 At American Heart Association (AHA) By : Cardiology News
Surface Logix Inc. today announced the presentation of positive data from its first Phase 1 clinical trial assessing the safety and tolerability and establishing the pharmacokinetic and pharmacodynamic profile of its investigational drug candidate, SLx-4090, an enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor being developed for the treatment of dyslipidemia (abnormal levels of lipids in the bloodstream). - Kensey Nash Announces Commencement Of Carotid Pivotal Trial For TriActiv ProGuard System By : Cardiology News
Kensey Nash Corporation (Nasdaq: KNSY) today announced that it has commenced enrollment of a 300 to 400 patient pivotal study for its TriActiv ProGuard Embolic Protection System in carotid stenting procedures. If successful, the PROGUARD trial will support a 510(k) submission, currently anticipated in early 2008 following the expected completion of enrollment. - 50,000 Angioplasties Each Year Of No Benefit By : Cardiology News
Tens of thousands of angioplasty procedures carried out each year in the USA after heart attacks are not only a waste of time and resources, but they could also be dangerous for the patients, say experts after looking at 2,166 cases. - Minneapolis Heart Institute Foundation Collaborates with Other Minnesota Health Care Providers By : Health News
The Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital has partnered with three Minnesota health care providers to create the Minnesota Cardiovascular Cell Therapy Clinical Research Network (MnCTN), which recently received a $1.5 million grant from the National Institute of Health (NIH) to research stem cell treatments for heart disease. - TRPC6 Is Big Hearted By : Cardiology News
The causes of heart failure are extremely diverse and include high blood pressure, a heart attack, and inherited genetic abnormalities. Two of the reasons these events all trigger heart failure is that they result in the muscle cells of the heart getting bigger (a process known as cardiac hypertrophy) and they cause the muscle cells to change the types of protein they express (and so change their functions). - How To Grow Muscle Cells In A Dish By : Cardiology News
Smooth muscle cells (SMCs) are a crucial cellular component of many parts of the body, including blood vessels, the intestines, and the lungs. SMCs in the blood vessels are involved in several causes of heart disease and understanding how SMCs are generated is important for designing therapies for such diseases. It is also knowledge that could be used to engineer tissues in the laboratory, for example new blood vessels for use in bypass surgery. - Aortic Aneurysms Are Often Familial Diseases By : Cardiology News
A detailed study of 520 patients with thoracic aortic aneurysm (TAA) and dissection indicates a very strong genetic link, Yale School of Medicine researchers report in the Annals of Thoracic Surgery. - Higher Death Rate For Heart Attack Patients With Additional Non-Cardiac Conditions By : Cardiology News
Heart attack patients who also have another acute condition such as stroke, kidney failure and pneumonia may have a poorer outcome than those without these conditions, and those with the most severe conditions account for a disproportionate percentage of hospital deaths, researchers at Yale School of Medicine report in a recent American Journal of Medicine. - Seriousness Of Heart Failure In Elderly Gauged By Seven-Point System By : Cardiology News
A simple points system may soon help guide treatment of elderly heart failure patients. Researchers at Washington University School of Medicine in St. Louis found that by counting how many of seven easy-to-obtain health factors a patient has, physicians can estimate the patient's risk of dying. - Scios Announces Selection Of Independent Executive Committee And Planned Protocol Design By : Cardiology News
Scios Inc. today announced the 13 heart failure experts from North America and Europe who will serve on the independent executive committee that will lead the ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure) trial. Scios also described the general design features of the protocol for this global, multi-center outcomes study of approximately 7,000 patients. - Alteon's ALT-2074 Demonstrates Ability To Reduce Infarct Size By 80 Percent In Mice With Haptoglobin By : Cardiology News
Alteon Inc. (Amex: ALT) announced today that data demonstrating the ability of its compound ALT-2074 (formerly BXT-51072 licensed from OXIS International, Inc., OTC Bulletin Board: OXIS.OB), to reduce myocardial injury in mice is the subject of an abstract being presented at the American Heart Association Scientific Sessions 2006 in Chicago, IL, by a research team from the Rappaport Institute, Israel. - Low Carb-Diets Focusing On Vegetable-Based Sources Of Fat And Protein May Reduce Risk Of CHD By : Cardiology News
Advocates of low-carbohydrate diets, such as the popular Atkins diet, claim that those diets may help prevent obesity and coronary heart disease (CHD). However, the long-term safety of those diets has been debated, particularly because they encourage the consumption of animal products. - New Research Questions Safety Of T-PA Clot-Busting Therapy By : Cardiology News
Across the world, emergency medical teams often administer a powerful clot-busting drug called tissue plasminogen activator (t-PA) to help patients stricken by heart attack. - Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug By : Cardiology News
Studies of a rare genetic condition that increases cancer risk have unveiled a potential treatment for metabolic syndrome, a common disorder that afflicts as many as one in every four American adults and puts them at sharply increased risk of type 2 diabetes and clogged arteries. - Systolic Blood Pressure Level For Patients With Heart Failure May Help Predict Risk Of Death By : Cardiology News
Patients with heart failure and low systolic blood pressure at hospital admission are more likely to have poor outcomes including higher mortality rates and increased rates of rehospitalization, despite medical treatment, according to a study in the November 8 issue of JAMA. - Some Factors Related To Heart Function And Linked With Heart Failure More Common Than Believed By : Cardiology News
Several factors related to heart function and that play a role in heart failure are more prevalent than previously thought, according to a study in the November 8 issue of JAMA. - Mayo Clinic Reveals Abnormality In Filling Of The Heart Is Frequent Culprit Of Heart Failure By : Cardiology News
Difficulties in the heart's ability to fill with blood are common causes of heart failure -- and appear to be as significant in placing a heart patient at risk of death as are deficiencies in the heart's ability to pump blood, new research from Mayo Clinic shows. - Heart Failure: Abnormality In Filling Of The Heart Is Frequent Culprit By : Cardiology News
Difficulties in the heart's ability to fill with blood are common causes of heart failure -- and appear to be as significant in placing a heart patient at risk of death as are deficiencies in the heart's ability to pump blood, new research from Mayo Clinic shows. - Systolic Blood Pressure Predicts Mortality In Heart Failure Patients By : Cardiology News
Systolic blood pressure, a readily available vital sign taken at hospital admission, has been found to be a key factor in predicting mortality risk and revealing important disease characteristics for heart failure patients, according to a team of academic researchers. - Tissue Plasminogen Activator May Help Spur Dangerous Heart Arrhythmias, Weill Cornell Team Reports By : Cardiology News
Across the world, emergency medical teams often administer a powerful clot-busting drug called tissue plasminogen activator (t-PA) to help patients stricken by heart attack. - Heart Failure Rx: Pacemakers, Not Beta Blockers, May Be Best For Some Patients By : Cardiology News
Researchers at Johns Hopkins have reported evidence to support a dramatic change in the way hundreds of thousands of Americans with a form of heart failure should be treated. - Heart Failure Rx: Pacemakers, Not Beta Blockers, May Be Best For Some Patients By : Cardiology News
Researchers at Johns Hopkins have reported evidence to support a dramatic change in the way hundreds of thousands of Americans with a form of heart failure should be treated. - Cleveland Clinic-Led Study Shows Self-Administered Blood Thinners Are Safe For Atrial Fibrilation By : Cardiology News
The use of self-administered blood thinners in patients undergoing treatment for atrial fibrillation is as safe as administering anticoagulants intravenously and may result in better outcomes, including shorter hospital stays and improved heart rhythm five weeks after treatment. These are the findings of a Cleveland Clinic-led study that will be published in the Nov. 28th issue of the European Heart Journal. - Genetic 'Missing Link' Sheds Light On Sudden Cardiac Death By : Cardiology News
An electrical imbalance caused by a malfunctioning gene triggers a potentially fatal heart rhythm disorder, according to researchers at Baylor College of Medicine (BCM) and Texas Children's Hospital in Houston. - Successful Results Of The 'Randomized, Prospective, Multi-Center Trial' For The MedClose(TM) VCS By : Cardiology News
CPC of America, Inc. (OTC Bulletin Board: CPCF) reports that its subsidiary, Med Enclosure, LLC, continues to report successful results with no adverse affects in both diagnostic and interventional clinical patients of the "Randomized, Prospective, Multi-Center Trial of the MedClose(TM) VCS." Comments from clinical investigators.
|
